[HTML][HTML] Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: phase II, randomized, dose-scheduling, observer-blind study
MR Capeding, A Sil, BT Tadesse, T Saluja… - …, 2020 - thelancet.com
Background Typhoid causes significant mortality among young children in resource-limited
settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths …
settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths …
[PDF][PDF] Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study
MR Capeding, A Sil, BT Tadesse, T Saluja, S Teshome… - age - scienceopen.com
Background: Typhoid causes significant mortality among young children in resource-limited
settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths …
settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths …
Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study
MR Capeding, A Sil, BT Tadesse… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Typhoid causes significant mortality among young children in resource-limited
settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths …
settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths …
[HTML][HTML] Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study
MR Capeding, A Sil, BT Tadesse, T Saluja… - …, 2020 - ncbi.nlm.nih.gov
Background Typhoid causes significant mortality among young children in resource-limited
settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths …
settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths …
[PDF][PDF] Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study
MR Capeding, A Sil, BT Tadesse, T Saluja, S Teshome… - age - researchgate.net
Background: Typhoid causes significant mortality among young children in resource-limited
settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths …
settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths …
Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study.
MR Capeding, A Sil, BT Tadesse, T Saluja… - …, 2020 - europepmc.org
Background Typhoid causes significant mortality among young children in resource-limited
settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths …
settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths …
[HTML][HTML] Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study
MR Capeding, A Sil, BT Tadesse, T Saluja, S Teshome… - EClinicalMedicine, 2020 - Elsevier
Background Typhoid causes significant mortality among young children in resource-limited
settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths …
settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths …